Anticoagulation, Thombin Generation and Factor XI inhibition in ACS and Atrial Fibrillation with Dr C. Michael Gibson
Future Pulse Cardiology06/25/23 • 30 min
Dr. Thomas Nero discusses current therapy with Factor X inhibitors, the new research with Factor XI inhibition and specifically the enrolling Milvexian clinical trials with Dr. C Micahel Gibson. In addition they discuss, the addition of these medications along wiht anti-platelet therapy, Lp(a) and other interesting current and future research in cardiovascular disease.
06/25/23 • 30 min
Future Pulse Cardiology - Anticoagulation, Thombin Generation and Factor XI inhibition in ACS and Atrial Fibrillation with Dr C. Michael Gibson
Transcript
[00:00:00] Dr. Thomas Nero: Good afternoon and welcome to Future Pulse. I'm Dr. Thomas Nero today we have the pleasure of discussing Factor XIa inhibitors with Dr. Michael Gibson. Dr. Gibson is an interventional cardiologist, a cardiovascular research and educator. He's the CEO of the Baim Research Institute at Harvard Medical School.
He has offered thousands and thousands of papers on clinical trials in interventional cardiology, preventive cardiology, public health, an
Generate a badge
Get a badge for your website that links back to this episode
<a href="https://goodpods.com/podcasts/future-pulse-cardiology-277889/anticoagulation-thombin-generation-and-factor-xi-inhibition-in-acs-and-34302553"> <img src="https://storage.googleapis.com/goodpods-images-bucket/badges/generic-badge-1.svg" alt="listen to anticoagulation, thombin generation and factor xi inhibition in acs and atrial fibrillation with dr c. michael gibson on goodpods" style="width: 225px" /> </a>
Copy